2020
DOI: 10.1016/j.plabm.2020.e00188
|View full text |Cite
|
Sign up to set email alerts
|

Real-world use of key performance indicators for point-of-Care Testing network accredited by ISO 22870

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 14 publications
0
4
0
Order By: Relevance
“…In addition, they also reported that the ratios for insufficient samples for the two groups were 2.9% and 0.9%, respectively. Similarly, Oliver et al (10) did not provide any specific total SRR; however, they reported that BGA SRR specific to each department would be expected to be less than 10% . Accordingly, they reported that only BGA SRRs of the samples received from the Delivery room exceeded 10% during certain months and the most frequent causes for sample rejection were often associated with the preanalytical phase.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…In addition, they also reported that the ratios for insufficient samples for the two groups were 2.9% and 0.9%, respectively. Similarly, Oliver et al (10) did not provide any specific total SRR; however, they reported that BGA SRR specific to each department would be expected to be less than 10% . Accordingly, they reported that only BGA SRRs of the samples received from the Delivery room exceeded 10% during certain months and the most frequent causes for sample rejection were often associated with the preanalytical phase.…”
Section: Discussionmentioning
confidence: 98%
“…Additionally, BGA collection is technically challenging for the phlebotomy staff and may also be painful for the patient from whom the blood sample is collected (9). Therefore, the requirement for resampling in addition to causing a delay in the diagnosis and treatment opportunities in case of BGA sample rejection can be troublesome (10,11). Moreover, other problems such as obtaining inaccurate results or equipment failure may also arise due to lack to identify inappropriate BGA samples (e.g., micro clots, air bubbles, etc.)…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pre-analytical error might occur and it can affect the results. Any laboratory tool has to be approved and should be accredited according to the international clinical laboratory standards such as Clinical Laboratory Improvement Amendments (CLIA) standards proposed by the Centre for Clinical Standards and Quality (CCSQ) 2 . Also, it is necessary to assess the precision of the test.…”
mentioning
confidence: 99%